PMID: 11933055Apr 5, 2002Paper

Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression

Journal of Neuroscience Research
L FerraroT Antonelli

Abstract

The present in vivo microdialysis study evaluates the possible existence of a differential regulation of serotonergic transmission by the antinarcoleptic drug modafinil [(diphenyl-methyl)-sulfinyl-2-acetamide; Modiodal] among various brain regions of the awake rat. The results show that, in the cerebral cortex, the central amygdala, and the dorsal raphe nucleus, modafinil in the dose range of 10-100 mg/kg i.p. dose-dependently increases dialysate serotonin (5-HT) levels. In other brain areas, such as the medial preoptic area and the posterior hypothalamus, the modafinil-induced increase in dialysate 5-HT levels is observed only at tenfold higher doses (100 mg/kg), 10-30 mg/kg being ineffective. Together these data suggest that, in the frontal cortex, the amygdala, and the dorsal raphe, modafinil is more potent in enhancing extracellular 5-HT levels and presumably 5-HT transmission than in the medial preoptic area and the posterior hypothalamus. In view of the role of ascending 5-HT pathways in arousal and depression, it seems likely that the antinarcoleptic drug modafinil may also have an antidepressant potential in addition to its wakefulness-promoting action, both actions involving enhancement of 5-HT neurotransmission.

References

Jan 23, 1976·Brain Research·D J McGinty, R M Harper
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Feb 1, 1968·The Journal of Pharmacy and Pharmacology·A CarlssonU Ungerstedt
Dec 1, 1968·The Journal of Pharmacy and Pharmacology·P F Cooper, G C Wood
Aug 5, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C C Meltzer, C F Reynolds
Aug 5, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M Jouvet
Jun 10, 2000·The Journal of Clinical Psychiatry·M A MenzaA Castellanos

❮ Previous
Next ❯

Citations

Oct 29, 2003·Pediatric Neurology·Thomas A Rugino, Teresa C Samsock
Nov 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alessandro GozziMarina Bentivoglio
Aug 31, 2006·Behavioural Pharmacology·Sanneke A M van VlietIngrid H C H M Philippens
Jul 25, 2006·The International Journal of Neuroscience·Reuven Sandyk
Feb 15, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P De RonA Nogueira da Costa
Jul 1, 2015·Sexual Medicine Reviews·Chris G McMahon
Oct 3, 2009·The Journal of Sexual Medicine·Lesley MarsonNeal M Farber
Nov 27, 2010·Biological Psychiatry·Linda ScorielsPeter B Jones
Feb 23, 2010·Journal of Psychiatric Research·J BeckE Holsboer-Trachsler
Oct 31, 2006·Neuropharmacology·T M KorotkovaO A Sergeeva
Feb 16, 2008·Journal of Sleep Research·Eun Yeon JooSeung Bong Hong
Sep 1, 2004·Sleep Medicine Reviews·Dev BanerjeeRonald R Grunstein
Dec 21, 2017·F1000Research·Odunayo KalejaiyeSuks Minhas
Jan 8, 2004·Journal of Clinical Psychopharmacology·Charles DeBattistaJennifer Poirier
Apr 3, 2003·Human Psychopharmacology·Delia C RandallSandra E File
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael J Minzenberg, Cameron S Carter
Oct 28, 2015·Nature Reviews. Urology·Theodore R Saitz, Ege Can Serefoglu
Dec 18, 2013·Pharmacological Reviews·Suzanne WoodStephan G Anagnostaras
Mar 7, 2014·Journal of Neurophysiology·J E KoschnitzkyC J Heckman
Jan 18, 2020·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Ana Sousa, Ricardo Jorge Dinis-Oliveira
Feb 9, 2005·International Journal of Immunopathology and Pharmacology·L LeggioG Gasbarrini
Feb 24, 2017·PeerJ·Adrian Johnson, Trevor James Hamilton
Jun 4, 2019·Frontiers in Psychiatry·Yuji YamadaTomiki Sumiyoshi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.